VACSERA launches Egyptian-made vaccine production line
The Holding Company for Biological Products and Vaccines (VACSERA) - Photo Courtesy Of VACSERA Official Facebook Page

CAIRO: The Holding Company for Biological Products and Vaccines (VACSERA) held a press conference Wednesday to announce the launch of an Egyptian-made vaccine production line, Youm7 reported.

Chairman of the company’s board, Nabil el-Beblawy, said there is currently no vaccination for MERS-CoV (Middle East respiratory syndrome coronavirus), stressing that there is only one confirmed case in Egypt.

Beblawy added at the conference that $12 million has been dedicated from an Emirati grant to develop the production line, according to Al-Ahram.

He warned Egyptians about pharmacists who claim that there are antisera, or serums containing antibodies for immunity, for MERS-CoV.

Vice president of the vaccinations center in the company, Dr. Khaled Adel, said that some vaccinations could help in minimizing the complications of the virus.

Assistant Minister of Health Dr. Abdel Hamid Abaza said the ministry spends 2 million EGP daily to provide interferon drugs for treatment, Youm7 reported.

Abaza also said VACSERA suffers from many issues but they make an effort to provide Egyptian-made medicines, Sada El Balad reported.

Additional reporting by Dana el-Hadidi.

Recommend to friends

Leave a comment